C3156138||endocannabinoid system
C0542478||physiological response
C0265101||carotid artery occlusion
C0684253||reperfusion
C1695782||global cerebral hypoperfusion
C0684253||reperfusion
C1386627||Bilateral Common Carotid Artery Occlusion
C0684253||Reperfusion
C1386627||BCCAO
C0684253||R
C0542478||physiological response
C3156138||endocannabinoid system
C3156138||endocannabinoid system
C0166415||peroxisome-proliferator activated receptor-alpha
C0166415||peroxisome-proliferator activated receptor-alpha
C0443264||modulating
C0242606||oxidative stress
C0021368||inflammation
C0008972||study
C0220825||evaluate
C3156138||endocannabinoid system
C0014442||enzyme
C0387583||cyclooxygenase-2
C0387583||cyclooxygenase-2
C0166415||peroxisome-proliferator activated receptor-alpha
C1386627||BCCAO
C0684253||R
C1882598||rat brain
C0005516||markers
C1386627||BCCAO
C0684253||R
C0032105||plasma
C0034716||Wistar rats
C1386627||BCCAO
C0684253||R
C0442856||hypoperfusion
C0684253||reperfusion
C0016733||frontal
C0039485||temporal
C3811911||occipital cortices
C0032105||plasma
C0936012||analyzed
C3641325||high performance liquid chromatography-mass spectrometry
C3641325||high performance liquid chromatography-mass spectrometry
C1172779||endocannabinoids
C1172779||endocannabinoids
C0023688||ligands
C0166415||peroxisome-proliferator activated receptor-alpha
C0242606||oxidative-stress
C0005516||markers
C0023776||lipoperoxides
C0949466||Western Blot
C0021044||immunohistochemistry
C0008972||study
C1171362||protein expression
C0054594||cannabinoid receptors
C0387583||cyclooxygenase-2
C0166415||peroxisome-proliferator activated receptor-alpha
C1710574||Unpaired Student's t-test
C0220825||evaluate
C1386627||BCCAO
C0684253||R
C0459385||brain tissue
C1172779||endocannabinoids
C0299477||2-arachidonoylglycerol
C0211726||anandamide
C0069964||palmitoylethanolamide
C0023688||ligand
C0166415||peroxisome-proliferator activated receptor-alpha
C0023776||lipoperoxides
C0378126||type 1
C0378126||CB1
C0208757||type 2
C0208757||CB2
C0054594||cannabinoid receptors
C0387583||cyclooxygenase-2
C0459385||brain tissue
C0012968||docosahexaenoic acid
C0012968||docosahexaenoic acid
C0023775||lipid peroxidation
C0032105||plasma
C0211726||anandamide
C0023776||lipoperoxides
C1386627||BCCAO
C0684253||R
C0459385||brain tissue
C0032105||plasma
C0040300||tissue
C0542478||physiological response
C0684253||reperfusion
C0242606||oxidative stress
C0021368||inflammation
C0443264||modulation
C3156138||endocannabinoid system
C0574031||proinflammatory
C0032105||plasmatic
C0211726||anandamide
C0023776||lipoperoxides
C1327622||dysregulation
C0442856||hypoperfusion
C0684253||reperfusion